Stocks & ETFunds

This is likely still a great time to own risk assets like stocks, commodities, digital assets, and other investment vehicles that should outperform negative-yielding inflation-adjusted bonds and other stagnant growth instruments.

Some investors might not be aware that SPDR Gold Trust (GLD) does not, in ordinary circumstances, allow for the redemption of physical gold while the Sprott Physical Gold Trust (PHYS) has the unique property of allowing investors to trade in their shares for physical gold deliveries. This article takes a look at the performance, liquidity and purpose of each to determine which is best under which circumstances.

Most commentators don't take into account the different marijuana sector categories which conveys a distorted picture of the health of the sector. The launch of the munKNEE Ancillary Pot Stocks Index corrects the situation by tracking the performance of 16 companies that provide goods and services to cannabis operators separately and acting as a complement to its Pure-Play American MSO Pot Stocks Index and Pure-Play Canadian LP Pot Stocks Index. 

The American Multi-State Operators (MSOs) component of the  munKNEE Pure-Play Pot Stock Index has 22 constituents and it dropped 4.5% this past week compared to a decline of 9.6% for the Canadian Licensed Producers (LP) component.

41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week only 9 went up in price while 31 went down and 1 had no change in price.

The decline in the Canadian Licensed Producers (LP) component of the munKNEE Pure-Play Pot Stock Index accelerated last week (-9.6%) after having declined the previous week (-8.2%) and is now down 17.0% so far in April.

 If you are looking for gold companies to invest in, knowing where Eric Sprott is investing is a good place to start and we have done just that, in part, for you, in this article.

In the space of six months since its public listing Canbud Distribution Corporation (CSE: CBDX; FSE: CD0) has entered into 3 product categories, namely: unique cultivation of hemp for cannabinoids (CBD) production,  research and development of mushrooms for both psychedelic pharmaceuticals and non-psychedelic nutraceuticals, and the commercialization of plant-based food products.

In the current craze where valuations don’t matter, where folks are chasing lottery-type returns, and where the government’s spending trillions of dollars in handouts and bailouts – there is a fly in the ointment - vast amounts of leverage, including stock market leverage.

41 psychedelic drug stocks trade on the various North American stock exchanges and 38 of them are down since the end of February for an overall sector change of -22.6%.